Trials / Completed
CompletedNCT05239598
Povidone-Iodine Oral Rinse Study
A Phase II, Randomized Trial to Test the Effect of Povidone-iodine 0.5% as Mouthwash/Gargle on SARS-CoV-2 Load (COVID 19) as an Adjuvant Infection Control Measure in Dental Practice
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a two-arm, randomized, 2-phase study. Phase I will be double blinded clinical trial of the safety and efficacy of an antiseptic mouthwash solution on reducing SARS-CoV-2 load in COVID 19+ adult individuals. Phase II is designed as an open label trial, and all subjects will receive the active mouthwash.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mouth rinse | Subjects will be asked to rinse/gargle one time with 10 mL of assigned mouth rinse for 30 seconds. |
Timeline
- Start date
- 2022-02-07
- Primary completion
- 2022-07-07
- Completion
- 2022-07-13
- First posted
- 2022-02-15
- Last updated
- 2023-08-14
- Results posted
- 2023-08-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05239598. Inclusion in this directory is not an endorsement.